Merieux Developpement is a venture capital fund investing in early and growth-stage companies in agriculture technology, climate solutions, biotechnology, and health technology. They provide financial support with checks ranging from $500k to $10M. Notable investments include Biobest and Amyl Therapeutics. Managed by Merieux Equity Partners and registered with the French Financial Markets Authority, the fund offers extensive industry expertise and cross-border experience. With over $1 billion managed, they have supported more than 45 companies in Europe and North America.
